We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+5.03%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$613M
AUM Growth
+$11.1M
Cap. Flow
+$98.2M
Cap. Flow %
16.02%
Top 10 Hldgs %
52.71%
Holding
630
New
243
Increased
56
Reduced
99
Closed
199

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$60.6M
2
ALBO
Albireo Pharma Inc
ALBO
+$17.5M
3
AVPT icon
AvePoint
AVPT
+$14.1M
4
SST icon
System1
SST
+$10.2M
5
MCD icon
McDonald's
MCD
+$10M

Sector Composition

Rank Sector Weight
1 Healthcare 14.03%
2 Consumer Discretionary 13.24%
3 Financials 8.37%
4 Technology 6.29%
5 Industrials 3.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
XLV icon
526
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$44B
-20,000
Closed -$9K
QTTB icon
527
Q32 Bio
QTTB
$452M
-7,313
Closed -$2M
CTEV
528
Claritev Corp
CTEV
$580M
-3,855
Closed -$1.66M
NKLA
529
CALL
DELISTED
Nikola Corporation Common Stock
NKLA
-1,913
Closed -$65K
GOEVW
530
DELISTED
Canoo Inc. Warrant
GOEVW
-226,175
Closed -$249K
BROGW
531
DELISTED
Brooge Holdings Limited Warrant expiring 12/20/2024
BROGW
-83,877
Closed -$41K
SAVE
532
DELISTED
Spirit Airlines, Inc.
SAVE
-101,700
Closed -$1.81M
SAVE
533
PUT
DELISTED
Spirit Airlines, Inc.
SAVE
-101,700
Closed -$754K
DNMR
534
DELISTED
Danimer Scientific, Inc.
DNMR
-263
Closed -$103K
DSKE
535
DELISTED
Daseke, Inc. Common Stock
DSKE
-20,000
Closed -$79K
CBAY
536
DELISTED
Cymabay Therapeutics
CBAY
-24,754
Closed -$86K
CBAY
537
PUT
DELISTED
Cymabay Therapeutics
CBAY
-40,000
Closed -$25K
THWWW
538
DELISTED
Target Hospitality Corp. Warrant expiring 3/15/2024
THWWW
-621,084
Closed -$62K
GOEV
539
DELISTED
Canoo Inc. Class A Common Stock
GOEV
-389
Closed -$1.92M
LVOXW
540
DELISTED
LiveVox Holding, Inc. Warrant
LVOXW
-18,790
Closed -$28K
MCOMW
541
DELISTED
micromobility.com Inc. Warrant
MCOMW
-542,860
Closed -$152K
ICPT
542
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-5,500
Closed -$2K
ICPT
543
PUT
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
-11,600
Closed -$65K
ZYNE
544
CALL
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-91,600
Closed -$29K
ZYNE
545
PUT
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
-50,000
Closed -$313K
DMS
546
DELISTED
Digital Media Solutions, Inc.
DMS
-3,133
Closed -$489K
KDNY
547
CALL
DELISTED
Chinook Therapeutics, Inc. Common Stock
KDNY
-3,000
Closed -$1K
IRNT
548
DELISTED
IronNet, Inc.
IRNT
-34,039
Closed -$338K
BLU
549
DELISTED
BELLUS Health Inc.
BLU
-1,625,883
Closed -$16.7M
VLDR
550
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
-10,268
Closed -$143K

Similar funds

Cowen and Company's Q3 2020 Portfolio in Review

As of Q3 2020, Cowen and Company held 630 positions worth $613M, up 1.8% from $601M the previous quarter. Its ten largest holdings account for 53% of the portfolio.

Cowen and Company deployed $98.2M of net new capital in Q3 2020, opening 243 new positions and adding to 56 existing holdings. Its largest new stake was Albireo Pharma Inc: 600,000 shares worth $20M.

By sector, the portfolio is most concentrated in Healthcare at 14% of assets, down from 14% a quarter earlier, followed by Consumer Discretionary and Financials.

On the sell side, the largest reduction was Arbutus Biopharma, an estimated $11.7M trimmed.

  • Cowen and Company's largest Q3 2020 buy was Albireo Pharma Inc: 600,000 shares worth $20M.
  • Cowen and Company added most to Invesco QQQ Trust in Q3 2020, an estimated $60.6M increase.
  • Cowen and Company's biggest Q3 2020 reduction was Arbutus Biopharma, cutting an estimated $11.7M.
  • Cowen and Company fully exited Carnival Corporation Ltd in Q3 2020, selling an estimated $24.2M.
  • Cowen and Company's ten largest holdings make up 53% of its $613M portfolio in Q3 2020.
  • Cowen and Company opened 243 new positions and closed 199 in Q3 2020.
  • Cowen and Company's portfolio value rose 1.8% quarter-over-quarter to $613M.

Based on Cowen and Company's 13F filing for Q3 2020, filed 3 Nov 2020.